Trial
NCT03704714
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Bristol-Myers Squibb; National Cancer Institute (NCI)
Condition
Aggressive Non-Hodgkin Lymphoma
Intervention
Cyclophosphamide
Why stopped
Protocol being amended for stats/accrual changes as per PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-15